The Bluefield Project to Cure Frontotemporal Dementia

The Bluefield Project to Cure Frontotemporal Dementia is a non-profit research foundation based in San Francisco, California. The organization is comprised of a small team of three employees and generates an annual revenue of $2.5 million. The Bluefield Project is dedicated to finding a treatment or cure for frontotemporal dementia (FTD), a devastating degenerative brain disease that primarily affects adults under the age of 65. The foundation funds a network of scientists and clinicians across the United States and the European Union to research the root causes of FTD and develop effective therapies. Their support encompasses a range of research efforts, including basic science, translational studies, clinical trials, and collaborative infrastructure projects. In addition to funding research, The Bluefield Project actively fosters data sharing and collaboration within the FTD research community. They have established several key initiatives, such as the FTD Registry (ftdregistry.org), the Neurofilament Surveillance Project (allftd.org/nsp), and data harmonization efforts for the FTD Prevention Initiative (thefpi.org). These initiatives aim to accelerate research progress and ultimately lead to the development of effective treatments for FTD. For more information about The Bluefield Project, please visit their website at www.bluefieldproject.org.